Brent Sabatini

SVP, Chief Accounting Officer, Vir Biotechnology, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

Jun 1, 2026

Companies

Vir Biotechnology, Inc.SVP, Chief Accounting Officer −$0.1M

Trades

VIR Sold 379 shares at $9.45 · planned $0.0M Jun 1

VIR Sold 7,711 shares at $9.12 · planned $0.1M Mar 23

VIR Sold 1,430 shares at $9.53 · planned $0.0M Feb 24

VIR Sold 1,829 shares at $7.45 · planned $0.0M Feb 23

VIR Sold 1,530 shares at $7.79 · planned $0.0M Feb 13

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.